Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
about
Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET.Phakomatoses. Part I: Neurofibromatosis type 1: common and uncommon neuroimaging findings.Neurofibromatosis 1: clinical manifestations and diagnostic criteria.Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study.New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.
P2860
Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
@en
Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
@nl
type
label
Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
@en
Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
@nl
prefLabel
Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
@en
Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
@nl
P2093
P356
P1476
Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
@en
P2093
G Bartalini
L Calistri
P Balestri
R Vivarelli
P2888
P304
P356
10.1007/BF00393546
P577
1993-12-01T00:00:00Z
P6179
1053033618